Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Johanna C. Bendell, Chloe Evelyn Atreya, Thierry André, Josep Tabernero, Michael S. Gordon, Rene Bernards, Eric Van Cutsem, Sabine Tejpar, Roger Sidhu, William Y. Go, Alicia Allred, Monica Motwani, Benjamin B. Suttle, Yuehui Wu, Axel Hoos, Keith W. Orford | ||||||||||||
Title | Efficacy and tolerability in an open-label phase I/II study of MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in combination in patients (pts) with BRAF V600E mutated colorectal cancer (CRC). | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/131642-144 | ||||||||||||
Abstract Text |